Shots:
Transforming care with advanced mechanisms of action, monoclonal antibody therapies hold a strong foothold in the healthcare market
In 2021, the monoclonal antibody therapy market size was valued at $178.5B and is envisioned to reach $451.89B by 2028, displaying a CAGR of 14.1%. Keytruda with $25.01B revenue ranks first in our list followed by…
